| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Schwartz Aharon is a Director at Protalix BioTherapeutics, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $16K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2025 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 129,000 | $1.60 | $205,884.00 | +74.1% | 0.0% | +25.9% | |
| Jan 3, 2023 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 110,000 | $1.42 | $155,815.00 | +171.9% | +61.3% | +30.7% | |
| Apr 7, 2020 | PLX Protalix Biotherapeutics, Inc. | Director | Buy | 64,000 | $2.43 | $155,264.00 | New | - | - |